Literature DB >> 24055804

Infectious etiology of acute exacerbations in severe COPD patients.

Arnau Domenech1, Carmen Puig, Sara Martí, Salud Santos, Anabel Fernández, Laura Calatayud, Jordi Dorca, Carmen Ardanuy, Josefina Liñares.   

Abstract

OBJECTIVES: Since the new GOLD guidelines were implemented no data have been published about the etiology of acute exacerbations (AECOPD) in severe COPD patients with a different frequency of annual episodes.
METHODS: One hundred and eleven COPD patients (FEV1 < 50%) were prospectively followed up for a year. Good-quality sputum samples recovered during AECOPD were processed, including quantitative culture and PCR detection of atypical bacteria.
RESULTS: A total of 188 sputum samples were obtained from AECOPD episodes. Forty patients had a single episode, and 71 patients had ≥2. In 128 episodes a single pathogen was isolated, while 42 episodes were polymicrobial (≥2 pathogens). Overall, the most frequent pathogen isolated was Pseudomonas aeruginosa (n = 54), followed by Haemophilus influenzae (n = 37), Streptococcus pneumoniae (n = 31), Moraxella catarrhalis (n = 29) and Staphylococcus aureus (n = 12). P. aeruginosa was the most frequent in both groups of patients (35% and 27% in those with 1 and ≥2 AECOPD, respectively). H. influenzae was associated with patients with a single annual AECOPD (33% vs. 16%; P = 0.006), while Enterobacteriaceae were associated with frequent exacerbators (0% vs. 12%; P < 0.044).
CONCLUSION: Overall, P. aeruginosa was the most frequent pathogen isolated from exacerbations. However, different bacterial etiology was observed depending on the number of annual episodes.
Copyright © 2013 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute exacerbation; Chronic obstructive pulmonary disease; Haemophilus influenzae; Pseudomonas aeruginosa; Streptococcus pneumoniae

Mesh:

Substances:

Year:  2013        PMID: 24055804     DOI: 10.1016/j.jinf.2013.09.003

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  18 in total

1.  Identification of outer membrane Porin D as a vitronectin-binding factor in cystic fibrosis clinical isolates of Pseudomonas aeruginosa.

Authors:  Magnus Paulsson; Birendra Singh; Tamim Al-Jubair; Yu-Ching Su; Niels Høiby; Kristian Riesbeck
Journal:  J Cyst Fibros       Date:  2015-06-03       Impact factor: 5.482

Review 2.  Potential impact of a Moraxella catarrhalis vaccine in COPD.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Vaccine       Date:  2017-02-06       Impact factor: 3.641

3.  Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.

Authors:  Hakan Tanrıverdi; Tacettin Örnek; Fatma Erboy; Bülent Altınsoy; Fırat Uygur; Figen Atalay; Müge Meltem Tor
Journal:  Wien Klin Wochenschr       Date:  2015-01-14       Impact factor: 1.704

4.  Increased biofilm formation by nontypeable Haemophilus influenzae isolates from patients with invasive disease or otitis media versus strains recovered from cases of respiratory infections.

Authors:  Carmen Puig; Arnau Domenech; Junkal Garmendia; Jeroen D Langereis; Pascal Mayer; Laura Calatayud; Josefina Liñares; Carmen Ardanuy; Sara Marti
Journal:  Appl Environ Microbiol       Date:  2014-09-05       Impact factor: 4.792

5.  Specific IgA against Pseudomonas aeruginosa in severe COPD.

Authors:  Laura Millares; Sara Martí; Carmen Ardanuy; Josefina Liñares; Salud Santos; Jordi Dorca; Marian García-Nuñez; Sara Quero; Eduard Monsó
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-09-30

6.  Bacteriological incidence in pneumonia patients with pulmonary emphysema: a bacterial floral analysis using the 16S ribosomal RNA gene in bronchoalveolar lavage fluid.

Authors:  Keisuke Naito; Kei Yamasaki; Kazuhiro Yatera; Kentaro Akata; Shingo Noguchi; Toshinori Kawanami; Kazumasa Fukuda; Takashi Kido; Hiroshi Ishimoto; Hiroshi Mukae
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-07-20

7.  Global scientific collaboration in COPD research.

Authors:  Yanbing Su; Chao Long; Qi Yu; Juan Zhang; Daisy Wu; Zhiguang Duan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-01-06

8.  Prevalence and resistance pattern of Moraxella catarrhalis in community-acquired lower respiratory tract infections.

Authors:  Safia Bader Uddin Shaikh; Zafar Ahmed; Syed Ali Arsalan; Sana Shafiq
Journal:  Infect Drug Resist       Date:  2015-07-31       Impact factor: 4.003

9.  Antimicrobial activity of mul-1867, a novel antimicrobial compound, against multidrug-resistant Pseudomonas aeruginosa.

Authors:  George Tetz; Daria Vikina; Victor Tetz
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-03-22       Impact factor: 3.944

10.  [Integral approach to the acute exacerbation of chronic obstructive pulmonary disease].

Authors:  J González Del Castillo; F J Candel; J de la Fuente; F Gordo; F J Martín-Sánchez; R Menéndez; A Mujal; J Barberán
Journal:  Rev Esp Quimioter       Date:  2018-10-04       Impact factor: 1.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.